Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1275-1281

  Mastronarde, John G ^b   Monick, Marty M ^b   Mukaida, Naofumi ^b   Matsushima, Kouji ^b   Hunninghake, Gary W ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ACETYLCYSTEINE; AMILORIDE; ANTIOXIDANT; DIMETHYL SULFOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; RIBAVIRIN; TRANSCRIPTION FACTOR AP 1;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING SITE; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRANSCRIPTION REGULATION;

EID: 0031925201     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515279     Document Type: Article

References (12)

1. Hall CD, McCarthy CA. Respiratory syncytial virus. In: Principles and practice of infectious diseases. Mandel GL, Bennet JE, Dolin R, eds. New York: Churchill Livingstone, 1995:1501-19.
2. Hall CB, Hall WJ, Gala CL. A long-term prospective study of children following respiratory syncytial virus infection. J Pediatr 1984;105:358-64.
3. Groothuis JR, Gutierre KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988;82: 199-203.
4. Aherne WT, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970;23:7-18.
5. Everhard M, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428-32.
6. Kunkel S, Standiford T, Kasahara K, Stricter R. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17:17-23.
7. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokine tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 1993;8:20-7.
8. Mastronarde JG, Monick MM, Hunninghake GW. Oxidant tone regulates IL-8 production in epithelium. Am J Resp Cell Mol Biol 1995;13:237-44.
9. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993;265: L472-8.
10. Fiedler MA, Wernke-Dollries K, Stark JM. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am J Physiol 1995;269:L865-72.
11. Garofalo R, Sabry M, Jamaluddin M, et al. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J Virol 1996; 70:8773-81.
12. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-κB and NF-IL6. J Infect Dis 1996;174:262-7.